Physiol Rev Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Rev. 80: 1669-1699, 2000;
0031-9333/00 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (130)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montrucchio, G.
Right arrow Articles by Camussi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montrucchio, G.
Right arrow Articles by Camussi, G.

Physiological Reviews, Vol. 80, No. 4, October 2000, pp. 1669-1699
Copyright ©2000 by the American Physiological Society

Role of Platelet-Activating Factor in Cardiovascular Pathophysiology

Giuseppe Montrucchio, Giuseppe Alloatti, and Giovanni Camussi

Laboratorio di Immunopatologia Renale, Dipartimento di Medicina Interna, Dipartimento di Biologia Animale e dell'Uomo e Istituto Nazionale di Fisica della Materia, Università di Torino, Torino, Italy

Montrucchio, Giuseppe, Giuseppe Alloatti, and Giovanni Camussi. Role of Platelet-Activating Factor in Cardiovascular Pathophysiology. Physiol. Rev. 80: 1669-1699, 2000.Platelet-activating factor (PAF) is a phospholipid mediator that belongs to a family of biologically active, structurally related alkyl phosphoglycerides. PAF acts via a specific receptor that is coupled with a G protein, which activates a phosphatidylinositol-specific phospholipase C. In this review we focus on the aspects that are more relevant for the cell biology of the cardiovascular system. The in vitro studies provided evidence for a role of PAF both as intercellular and intracellular messenger involved in cell-to-cell communication. In the cardiovascular system, PAF may have a role in embryogenesis because it stimulates endothelial cell migration and angiogenesis and may affect cardiac function because it exhibits mechanical and electrophysiological actions on cardiomyocytes. Moreover, PAF may contribute to modulation of blood pressure mainly by affecting the renal vascular circulation. In pathological conditions, PAF has been involved in the hypotension and cardiac dysfunctions occurring in various cardiovascular stress situations such as cardiac anaphylaxis and hemorrhagic, traumatic, and septic shock syndromes. In addition, experimental studies indicate that PAF has a critical role in the development of myocardial ischemia-reperfusion injury. Indeed, PAF cooperates in the recruitment of leukocytes in inflamed tissue by promoting adhesion to the endothelium and extravascular transmigration of leukocytes. The finding that human heart can produce PAF, expresses PAF receptor, and is sensitive to the negative inotropic action of PAF suggests that this mediator may have a role also in human cardiovascular pathophysiology.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2775 - H2784.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
X. Ding and P. A. Murray
The Differential Effects of Intravenous Anesthetics on Myofilament Ca2+ Sensitivity in Pulmonary Venous Smooth Muscle
Anesth. Analg., November 1, 2007; 105(5): 1278 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Doublier, M. Ceretto, E. Lupia, S. Bravo, B. Bussolati, and G. Camussi
The Proangiogenic Phenotype of Tumor-Derived Endothelial Cells is Reverted by the Overexpression of Platelet-Activating Factor Acetylhydrolase
Clin. Cancer Res., October 1, 2007; 13(19): 5710 - 5718.
[Abstract] [Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
Hardev Ramandeep Singh Girn, S. Ahilathirunayagam, A. I. D. Mavor, and S. Homer-Vanniasinkam
Reperfusion Syndrome: Cellular Mechanisms of Microvascular Dysfunction and Potential Therapeutic Strategies
Vascular and Endovascular Surgery, September 1, 2007; 41(4): 277 - 293.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Doukas, W. Wrasidlo, G. Noronha, E. Dneprovskaia, R. Fine, S. Weis, J. Hood, A. DeMaria, R. Soll, and D. Cheresh
Phosphoinositide 3-kinase {gamma}/{delta} inhibition limits infarct size after myocardial ischemia/reperfusion injury
PNAS, December 26, 2006; 103(52): 19866 - 19871.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. P. Winn, N. Daskalakis, R. F. Spurney, and J. P. Middleton
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications?
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 378 - 387.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. C. Meyer, M. H. Creer, and J. McHowat
Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium
Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1485 - C1491.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Wang, T. A. Fields, K. Pazmino, Q. Dai, J. L. Burchette, D. N. Howell, T. M. Coffman, and R. F. Spurney
Activation of G{alpha}q-Coupled Signaling Pathways in Glomerular Podocytes Promotes Renal Injury
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3611 - 3622.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. Hu, M. R. Salem, and G. J. Crystal
Isoflurane Prevents Platelets from Enhancing Neutrophil-Induced Coronary Endothelial Dysfunction
Anesth. Analg., November 1, 2005; 101(5): 1261 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Y. Kihara, S. Ishii, Y. Kita, A. Toda, A. Shimada, and T. Shimizu
Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor
J. Exp. Med., September 19, 2005; 202(6): 853 - 863.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Arakawa, J.-Y. Qian, D. Baatar, K. Karasawa, Y. Asada, Y. Sasaguri, E. R. Miller, J. L. Witztum, and H. Ueno
Local Expression of Platelet-Activating Factor-Acetylhydrolase Reduces Accumulation of Oxidized Lipoproteins and Inhibits Inflammation, Shear Stress-Induced Thrombosis, and Neointima Formation in Balloon-Injured Carotid Arteries in Nonhyperlipidemic Rabbits
Circulation, June 21, 2005; 111(24): 3302 - 3309.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Zhu and P. He
Platelet-activating factor increases endothelial [Ca2+]i and NO production in individually perfused intact microvessels
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2869 - H2877.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Penna, G. Alloatti, S. Cappello, D. Gattullo, G. Berta, B. Mognetti, G. Losano, and P. Pagliaro
Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2512 - H2520.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
H. Hudry-Clergeon, D. Stengel, E. Ninio, and I. Vilgrain
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase
FASEB J, April 1, 2005; 19(6): 512 - 520.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
N. Matsuda, Y. Hattori, S. Jesmin, and S. Gando
Nuclear Factor-{kappa}B Decoy Oligodeoxynucleotides Prevent Acute Lung Injury in Mice with Cecal Ligation and Puncture-Induced Sepsis
Mol. Pharmacol., April 1, 2005; 67(4): 1018 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
P. A. Lang, D. S. Kempe, V. Tanneur, K. Eisele, B. A. Klarl, S. Myssina, V. Jendrossek, S. Ishii, T. Shimizu, M. Waidmann, et al.
Stimulation of erythrocyte ceramide formation by platelet-activating factor
J. Cell Sci., March 15, 2005; 118(6): 1233 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gao and J. U. Raj
Role of veins in regulation of pulmonary circulation
Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L213 - L226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X.-B. Han, X. Liu, W. Hsueh, and I. G. De Plaen
Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor
Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1220 - G1226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
O. Chami, G. Evans, and C. O'Neill
Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E233 - E240.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
Y Yang, E M Nemoto, S A K Harvey, V M Subbotin, and C R Gandhi
Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis
Gut, June 1, 2004; 53(6): 877 - 883.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Rollin, C. Lemieux, R. Maliba, J. Favier, L. R. Villeneuve, B. G. Allen, S. Soker, N. G. Bazan, Y. Merhi, and M. G. Sirois
VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis
Blood, May 15, 2004; 103(10): 3789 - 3797.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Bouayad, J.-C. Fouron, X. Hou, M. Beauchamp, C. Quiniou, D. Abran, K. Peri, R. I. Clyman, D. R. Varma, and S. Chemtob
Developmental regulation of prostaglandin E2 synthase in porcine ductus arteriosus
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R903 - R909.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. Negrao-Correa, D. G. Souza, V. Pinho, M. M. Barsante, A. L. S. Souza, and M. M. Teixeira
Platelet-Activating Factor Receptor Deficiency Delays Elimination of Adult Worms but Reduces Fecundity in Strongyloides venezuelensis-Infected Mice
Infect. Immun., February 1, 2004; 72(2): 1135 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. J. Kell, M. H. Creer, K. N. Crown, K. Wirsig, and J. McHowat
Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1163 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. Alloatti, R. Levi, D. Malan, L. Del Sorbo, O. Bosco, L. Barberis, A. Marcantoni, I. Bedendi, C. Penna, O. Azzolino, et al.
Phosphoinositide 3-kinase {gamma}-deficient hearts are protected from the PAF-dependent depression of cardiac contractility
Cardiovasc Res, November 1, 2003; 60(2): 242 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Biancone, V. Cantaluppi, L. Del Sorbo, S. Russo, L. W. Tjoelker, and G. Camussi
Platelet-activating Factor Inactivation by Local Expression of Platelet-activating Factor Acetyl-Hydrolase Modifies Tumor Vascularization and Growth
Clin. Cancer Res., September 15, 2003; 9(11): 4214 - 4220.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Watanabe, G. K. Marathe, P. O. Neilsen, A. S. Weyrich, K. A. Harrison, R. C. Murphy, G. A. Zimmerman, and T. M. McIntyre
Endotoxins Stimulate Neutrophil Adhesion Followed by Synthesis and Release of Platelet-activating Factor in Microparticles
J. Biol. Chem., August 29, 2003; 278(35): 33161 - 33168.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Rodemer, T.-P. Thai, B. Brugger, T. Kaercher, H. Werner, K.-A. Nave, F. Wieland, K. Gorgas, and W. W. Just
Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice
Hum. Mol. Genet., August 1, 2003; 12(15): 1881 - 1895.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. J. Casillan, N. C. Gonzalez, J. S. Johnson, D. R. S. Steiner, and J. G. Wood
Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4
J Appl Physiol, June 1, 2003; 94(6): 2313 - 2322.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Hou, F. Gobeil Jr., A. M. Marrache, C. Quiniou, S. Brault, D. Checchin, S. G. Bernier, F. Sennlaub, J.-S. Joyal, D. Abran, et al.
Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R928 - R935.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. K. Handa, J. W. Strandhoy, C. E. Giammattei, and S. E. Handa
Platelet-activating factor and solute transport processes in the kidney
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F274 - F281.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
Y. Zhang, Y. Gu, M. J. Lucas, and Y. Wang
Antioxidant Superoxide Dismutase Attenuates Increased Endothelial Permeability Induced By Platelet-Activating Factor
Reproductive Sciences, January 1, 2003; 10(1): 5 - 10.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
A. M. Marrache, F. Gobeil Jr., S. G. Bernier, J. Stankova, M. Rola-Pleszczynski, S. Choufani, G. Bkaily, A. Bourdeau, M. G. Sirois, A. Vazquez-Tello, et al.
Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor
J. Immunol., December 1, 2002; 169(11): 6474 - 6481.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. H. Beauchamp, A. M. Marrache, X. Hou, F. Gobeil Jr, S. G. Bernier, P. Lachapelle, D. Abran, C. Quiniou, S. Brault, K. G. Peri, et al.
Platelet-Activating Factor in Vasoobliteration of Oxygen-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3327 - 3337.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Goggel, S. Hoffman, R. Nusing, S. Narumiya, and S. Uhlig
Platelet-Activating Factor-induced Pulmonary Edema Is Partly Mediated by Prostaglandin E2, E-Prostanoid 3-Receptors, and Potassium Channels
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 657 - 662.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Ahamed and H. Ali
Distinct Roles of Receptor Phosphorylation, G Protein Usage, and Mitogen-activated Protein Kinase Activation on Platelet Activating Factor-induced Leukotriene C4 Generation and Chemokine Production
J. Biol. Chem., June 14, 2002; 277(25): 22685 - 22691.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Barbuti, S. Ishii, T. Shimizu, R. B. Robinson, and S. J. Feinmark
Block of the background K+ channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2024 - H2030.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Valli and E.-G. V. Giardina
Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1083 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
G. A Ortolano, G. S Aldea, K. Lilly, P. O'Gara, J. D Alkon, F. Madera, T. Murad, C. P Altenbern, C. S Tritt, A. Capetandes, et al.
A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects
Perfusion, March 1, 2002; 17(2_suppl): 53 - 62.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
V. Stangl, G. Baumann, K. Stangl, and S. B Felix
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion
Cardiovasc Res, January 1, 2002; 53(1): 12 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Barbuti, S. Ishii, T. Shimizu, R. B. Robinson, and S. J. Feinmark
Block of the background K+ channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2024 - H2030.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online